| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |